Finance

Beta
Lists
NVCR:NASDAQ
Novocure Ltd
$17.99
+11.39%
(+1.84) 1D
$18.08
+0.50% (+0.090)
Pre-market
Closed: Jun 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVCR...
Open
$16.23
High
$18.39
Low
$16.23
Mkt. cap
2.08B
Avg. vol.
1.78M
Volume
3.34K
52-wk high
$19.25
52-wk low
$9.82
EPS
-$1.53
Beta
0.93
Shares outstanding
115.82M
No. of employees
2K
Open
$16.23
High
$18.39
Low
$16.23
Mkt. cap
2.08B
Avg. vol.
1.78M
Volume
3.34K
52-wk high
$19.25
52-wk low
$9.82
EPS
-$1.53
Beta
0.93
Shares outstanding
115.82M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to NVCR in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NVCR in the last 3 months.
Highest
Current $17.99
$48.00 (+166.81%)
Average
$26.00 (+44.52%)
Lowest
$17.00 (-5.50%)
News stories
From sources across the web
Stock Titan
Stock Titan
·
14 hours ago
[144] NovoCure Ltd SEC Filing
About Novocure Ltd
CEOAsaf Danziger
Employees1.6K
Founded2000
Headquarters-
SectorMedical device
Websitenovocure.com
Last report
Apr 30, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.62 / -$0.51
-20.89%miss
Revenue / Est. (USD)
174.06M / 168.70M
+3.17%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
158.80M
167.20M
174.35M
174.06M
Cost of goods sold
41.47M
44.73M
40.45M
38.93M
Cost of revenue
41.47M
44.73M
40.45M
38.93M
Research and development expenses
55.83M
54.03M
60.90M
58.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
101.02M
104.47M
110.18M
144.21M
Operating expense
156.85M
158.50M
171.09M
202.55M
Total operating expenses
198.33M
203.22M
211.53M
241.48M
Operating income
-39.52M
-36.02M
-37.18M
-67.42M
Other non operating income
-
-
-858.00K
-
EBT including unusual items
-34.98M
-30.02M
-40.95M
-69.26M
EBT excluding unusual items
-34.98M
-30.02M
-64.64M
-69.26M
Income tax expense
5.16M
7.25M
-16.46M
1.88M
Effective tax rate
-14.75%
-24.14%
40.18%
-2.71%
Other operating expenses
-
-
-
-
Net income
-40.14M
-37.27M
-24.50M
-71.14M
Net profit margin
-25.28%
-22.29%
-14.05%
-40.87%
Earnings per share
-0.36
-0.33
-0.22
-0.62
Interest and investment income
8.19M
9.80M
-
3.53M
Interest expense
-3.64M
-3.80M
-22.27M
-5.37M
Net interest expenses
4.54M
6.00M
-22.27M
-1.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.08M
-32.36M
-34.48M
-63.30M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer